Alkermes plc (ALKS)
USD 30.05
(-5.1%)
USD 30.05
(-5.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -166.73 Million USD | -21020.83% |
| 2022 | 797 Thousand USD | 101.91% |
| 2021 | -41.74 Million USD | -2187.0% |
| 2020 | 2 Million USD | -97.27% |
| 2019 | 73.36 Million USD | 484.78% |
| 2018 | 12.54 Million USD | -86.08% |
| 2017 | 90.14 Million USD | -7.35% |
| 2016 | 97.28 Million USD | -42.38% |
| 2015 | 168.83 Million USD | 26.08% |
| 2014 | 133.9 Million USD | -50.78% |
| 2013 | 272.04 Million USD | -24.61% |
| 2012 | 360.85 Million USD | -11.13% |
| 2011 | 406.06 Million USD | 1535.83% |
| 2010 | -28.28 Million USD | -156.98% |
| 2009 | -11 Million USD | -118.61% |
| 2008 | 59.13 Million USD | -24.17% |
| 2007 | 77.97 Million USD | -68.54% |
| 2006 | 247.83 Million USD | 7.57% |
| 2005 | 230.38 Million USD | 96.22% |
| 2004 | 117.41 Million USD | 15.22% |
| 2003 | 101.9 Million USD | -50.48% |
| 2002 | 205.8 Million USD | -5.1% |
| 2001 | 216.86 Million USD | -2.45% |
| 2000 | 222.31 Million USD | 641.02% |
| 1999 | 30 Million USD | 121.53% |
| 1998 | 13.54 Million USD | 16.12% |
| 1997 | 11.66 Million USD | -5.95% |
| 1996 | 12.4 Million USD | 24.0% |
| 1995 | 10 Million USD | 58.73% |
| 1994 | 6.3 Million USD | 142.31% |
| 1993 | 2.6 Million USD | 192.86% |
| 1992 | -2.8 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -50.64 Million USD | 69.63% |
| 2024 Q3 | -107.47 Million USD | 81.88% |
| 2024 Q2 | -167.14 Million USD | -230.03% |
| 2023 Q3 | -356.34 Million USD | 4.67% |
| 2023 Q2 | -373.79 Million USD | -1199.43% |
| 2023 Q4 | -166.73 Million USD | 53.21% |
| 2023 Q1 | -28.76 Million USD | -3709.28% |
| 2023 FY | -166.73 Million USD | -21020.83% |
| 2022 Q1 | 132.77 Million USD | 418.09% |
| 2022 Q2 | 155.66 Million USD | 17.24% |
| 2022 Q3 | 141.43 Million USD | -9.14% |
| 2022 Q4 | 797 Thousand USD | -99.44% |
| 2022 FY | 797 Thousand USD | 101.91% |
| 2021 FY | -41.74 Million USD | -2187.0% |
| 2021 Q3 | -14 Million USD | -108.43% |
| 2021 Q2 | 166.24 Million USD | -25.79% |
| 2021 Q4 | -41.74 Million USD | -197.99% |
| 2021 Q1 | 224.01 Million USD | 11100.55% |
| 2020 Q2 | 201.78 Million USD | -7.49% |
| 2020 Q4 | 2 Million USD | -98.62% |
| 2020 FY | 2 Million USD | -97.27% |
| 2020 Q1 | 218.12 Million USD | 197.31% |
| 2020 Q3 | 144.73 Million USD | -28.27% |
| 2019 Q1 | 53.53 Million USD | 326.69% |
| 2019 Q4 | 73.36 Million USD | 132.62% |
| 2019 Q3 | 31.53 Million USD | -68.41% |
| 2019 Q2 | 99.84 Million USD | 86.51% |
| 2019 FY | 73.36 Million USD | 484.78% |
| 2018 Q1 | 94.42 Million USD | 4.75% |
| 2018 Q4 | 12.54 Million USD | -80.34% |
| 2018 Q3 | 63.8 Million USD | -48.77% |
| 2018 Q2 | 124.54 Million USD | 31.89% |
| 2018 FY | 12.54 Million USD | -86.08% |
| 2017 FY | 90.14 Million USD | -7.35% |
| 2017 Q4 | 90.14 Million USD | -22.87% |
| 2017 Q3 | 116.87 Million USD | -6.09% |
| 2017 Q2 | 124.44 Million USD | 22.24% |
| 2017 Q1 | 101.8 Million USD | 4.64% |
| 2016 FY | 97.28 Million USD | -42.38% |
| 2016 Q4 | 97.28 Million USD | 16.74% |
| 2016 Q1 | 148.51 Million USD | -12.04% |
| 2016 Q2 | 150.59 Million USD | 1.4% |
| 2016 Q3 | 83.33 Million USD | -44.66% |
| 2015 Q3 | 130.88 Million USD | -17.12% |
| 2015 Q2 | 157.91 Million USD | 7.37% |
| 2015 Q4 | 168.83 Million USD | 29.0% |
| 2015 FY | 168.83 Million USD | 26.08% |
| 2015 Q1 | 147.07 Million USD | 9.83% |
| 2014 Q3 | 223.36 Million USD | 29.26% |
| 2014 Q2 | 172.81 Million USD | -16.27% |
| 2014 Q1 | 206.38 Million USD | 4.76% |
| 2014 FY | 133.9 Million USD | -50.78% |
| 2014 Q4 | 133.9 Million USD | -40.05% |
| 2013 Q1 | 272.04 Million USD | 16.65% |
| 2013 Q4 | 197 Million USD | 2.41% |
| 2013 Q3 | 192.36 Million USD | -23.37% |
| 2013 Q2 | 251.04 Million USD | -7.72% |
| 2013 FY | 272.04 Million USD | -24.61% |
| 2012 FY | 360.85 Million USD | -11.13% |
| 2012 Q1 | 360.85 Million USD | 0.4% |
| 2012 Q2 | 358.58 Million USD | -0.63% |
| 2012 Q3 | 238.17 Million USD | -33.58% |
| 2012 Q4 | 233.2 Million USD | -2.09% |
| 2011 Q4 | 359.43 Million USD | 1.26% |
| 2011 FY | 406.06 Million USD | 1535.83% |
| 2011 Q1 | -38.39 Million USD | 1.2% |
| 2011 Q2 | -35.94 Million USD | 6.37% |
| 2011 Q3 | 354.94 Million USD | 1087.42% |
| 2010 Q1 | -28.28 Million USD | -70.07% |
| 2010 FY | -28.28 Million USD | -156.98% |
| 2010 Q4 | -38.86 Million USD | -4.31% |
| 2010 Q3 | -37.25 Million USD | 17.66% |
| 2010 Q2 | -45.24 Million USD | -59.98% |
| 2009 Q1 | -11 Million USD | -137.72% |
| 2009 Q2 | 24.82 Million USD | 325.57% |
| 2009 Q3 | 10.53 Million USD | -57.55% |
| 2009 FY | -11 Million USD | -118.61% |
| 2009 Q4 | -16.62 Million USD | -257.82% |
| 2008 Q1 | 59.13 Million USD | 136.76% |
| 2008 Q3 | 23.36 Million USD | -42.83% |
| 2008 Q4 | 29.17 Million USD | 24.88% |
| 2008 FY | 59.13 Million USD | -24.17% |
| 2008 Q2 | 40.86 Million USD | -30.88% |
| 2007 Q3 | 73.11 Million USD | -25.41% |
| 2007 FY | 77.97 Million USD | -68.54% |
| 2007 Q1 | 77.97 Million USD | 3.43% |
| 2007 Q4 | -160.85 Million USD | -319.99% |
| 2007 Q2 | 98.02 Million USD | 25.7% |
| 2006 Q3 | 100.98 Million USD | 103.52% |
| 2006 Q1 | 247.83 Million USD | -11.46% |
| 2006 Q2 | 49.61 Million USD | -79.98% |
| 2006 FY | 247.83 Million USD | 7.57% |
| 2006 Q4 | 75.39 Million USD | -25.34% |
| 2005 FY | 230.38 Million USD | 96.22% |
| 2005 Q2 | 255.4 Million USD | 10.86% |
| 2005 Q1 | 230.38 Million USD | 146.53% |
| 2005 Q3 | 235.04 Million USD | -7.97% |
| 2005 Q4 | 279.89 Million USD | 19.08% |
| 2004 Q1 | 117.41 Million USD | 6.22% |
| 2004 Q2 | 120.68 Million USD | 2.78% |
| 2004 Q3 | 105.33 Million USD | -12.71% |
| 2004 Q4 | 93.45 Million USD | -11.28% |
| 2004 FY | 117.41 Million USD | 15.22% |
| 2003 Q2 | 134.19 Million USD | 31.69% |
| 2003 Q4 | 110.54 Million USD | 12.59% |
| 2003 Q3 | 98.17 Million USD | -26.84% |
| 2003 Q1 | 101.9 Million USD | 56.47% |
| 2003 FY | 101.9 Million USD | -50.48% |
| 2002 Q4 | 65.12 Million USD | 2273.55% |
| 2002 Q3 | -2.99 Million USD | -101.49% |
| 2002 Q2 | 201.23 Million USD | -2.22% |
| 2002 Q1 | 205.8 Million USD | -10.97% |
| 2002 FY | 205.8 Million USD | -5.1% |
| 2001 FY | 216.86 Million USD | -2.45% |
| 2001 Q1 | 216.86 Million USD | -1.36% |
| 2001 Q4 | 231.15 Million USD | 12.19% |
| 2001 Q3 | 206.04 Million USD | 1813.63% |
| 2001 Q2 | 10.76 Million USD | -95.04% |
| 2000 Q4 | 219.86 Million USD | 4.08% |
| 2000 FY | 222.31 Million USD | 641.02% |
| 2000 Q3 | 211.24 Million USD | -4.63% |
| 2000 Q1 | 222.31 Million USD | 668.26% |
| 2000 Q2 | 221.5 Million USD | -0.37% |
| 1999 FY | 30 Million USD | 121.53% |
| 1999 Q2 | 32.85 Million USD | 9.5% |
| 1999 Q3 | 28.45 Million USD | -13.39% |
| 1999 Q1 | 30 Million USD | 36.04% |
| 1999 Q4 | 28.93 Million USD | 1.7% |
| 1998 FY | 13.54 Million USD | 16.12% |
| 1998 Q1 | 13.54 Million USD | 41.94% |
| 1998 Q3 | 28.88 Million USD | 126.94% |
| 1998 Q4 | 22.05 Million USD | -23.66% |
| 1998 Q2 | 12.72 Million USD | -6.0% |
| 1997 Q4 | 9.54 Million USD | -26.56% |
| 1997 FY | 11.66 Million USD | -5.95% |
| 1997 Q1 | 11.66 Million USD | -23.47% |
| 1997 Q2 | 11.96 Million USD | 2.61% |
| 1997 Q3 | 12.99 Million USD | 8.56% |
| 1996 FY | 12.4 Million USD | 24.0% |
| 1996 Q2 | 11.28 Million USD | -8.96% |
| 1996 Q3 | 11.67 Million USD | 3.42% |
| 1996 Q1 | 12.4 Million USD | -10.14% |
| 1996 Q4 | 15.23 Million USD | 30.51% |
| 1995 Q1 | 10 Million USD | 31.58% |
| 1995 FY | 10 Million USD | 58.73% |
| 1995 Q3 | 8.3 Million USD | -10.75% |
| 1995 Q4 | 13.8 Million USD | 66.27% |
| 1995 Q2 | 9.3 Million USD | -7.0% |
| 1994 Q1 | 6.3 Million USD | 162.5% |
| 1994 Q2 | 7.7 Million USD | 22.22% |
| 1994 Q3 | 7.3 Million USD | -5.19% |
| 1994 Q4 | 7.6 Million USD | 4.11% |
| 1994 FY | 6.3 Million USD | 142.31% |
| 1993 Q2 | 1.2 Million USD | -53.85% |
| 1993 Q4 | 2.4 Million USD | 2500.0% |
| 1993 Q1 | 2.6 Million USD | 52.94% |
| 1993 Q3 | -100 Thousand USD | -108.33% |
| 1993 FY | 2.6 Million USD | 192.86% |
| 1992 Q3 | -1.7 Million USD | -88.89% |
| 1992 FY | -2.8 Million USD | 0.0% |
| 1992 Q2 | -900 Thousand USD | 67.86% |
| 1992 Q1 | -2.8 Million USD | 0.0% |
| 1992 Q4 | 1.7 Million USD | 200.0% |
| 1991 Q3 | -900 Thousand USD | -200.0% |
| 1991 Q2 | -300 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -198.068% |
| Agenus Inc. | 274.13 Million USD | 160.823% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 108.917% |
| Aptorum Group Limited | 1.35 Million USD | 12386.908% |
| Ardelyx, Inc. | 34.51 Million USD | 583.133% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3995.771% |
| Bicycle Therapeutics plc | -481.46 Million USD | 65.369% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 561.076% |
| ChromaDex Corporation | -24.04 Million USD | -593.359% |
| Chimerix, Inc. | -25.51 Million USD | -553.443% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2492.899% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -604.224% |
| CRISPR Therapeutics AG | -150.84 Million USD | -10.537% |
| Precision BioSciences, Inc. | -85.41 Million USD | -95.222% |
| Dyadic International, Inc. | -6.37 Million USD | -2514.243% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -946.501% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2275.329% |
| Lantern Pharma Inc. | -21.7 Million USD | -668.266% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -50.845% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1851.721% |
| Incyte Corporation | -3.17 Billion USD | 94.749% |
| IO Biotech, Inc. | -140.69 Million USD | -18.508% |
| Jaguar Health, Inc. | 29.39 Million USD | 667.313% |
| Novavax, Inc. | -298.29 Million USD | 44.102% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3224.208% |
| Opthea Limited | 28.15 Million USD | 692.167% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -893.144% |
| ContextLogic Inc. | -232 Million USD | 28.13% |
| MiMedx Group, Inc. | -33.9 Million USD | -391.841% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1735.498% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7096.248% |
| NextCure, Inc. | -6.47 Million USD | -2474.325% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -230.17% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2513.874% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1470.841% |
| Vaxcyte, Inc. | -368.22 Million USD | 54.718% |
| PDS Biotechnology Corporation | -32.7 Million USD | -409.766% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1065.036% |
| Pharming Group N.V. | 109.8 Million USD | 251.851% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -858.49% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 4.846% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -800.326% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -800.326% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2248.437% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2745.375% |
| Acelyrin, Inc. | -216.9 Million USD | 23.127% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2872.033% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -9571.636% |
| Summit Therapeutics Inc. | 34.67 Million USD | 580.876% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2350.963% |
| Senti Biosciences, Inc. | 1.74 Million USD | 9682.701% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 9.679% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -115.283% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2650.561% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 167225.059% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 26650.796% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -42.456% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 0.888% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 250.391% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2095.09% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -29.141% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2518.401% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 31.203% |
| Immix Biopharma, Inc. | -17.5 Million USD | -852.262% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 47.352% |
| MEI Pharma, Inc. | -3.7 Million USD | -4400.378% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1432.739% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 203.089% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 699.932% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2275.329% |
| Precigen, Inc. | -481 Thousand USD | -34565.073% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1284.142% |
| AlloVir, Inc. | -62.69 Million USD | -165.965% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -199.815% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 370.39% |
| ImmuCell Corporation | 10.99 Million USD | 1617.111% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -8.17% |
| Onconetix, Inc. | 5.33 Million USD | 3227.468% |
| PureTech Health plc | -167.19 Million USD | 0.274% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -447.403% |
| Elevation Oncology, Inc. | -19.11 Million USD | -772.157% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3296.598% |
| Seer, Inc. | -4.24 Million USD | -3832.524% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -593.676% |
| Innoviva, Inc. | 255.56 Million USD | 165.244% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -198.473% |
| ESSA Pharma Inc. | -33.62 Million USD | -395.928% |
| GlycoMimetics, Inc. | -40.98 Million USD | -306.835% |
| GT Biopharma, Inc. | -1.02 Million USD | -16230.95% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -145.989% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 372.196% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -24.359% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1103.37% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -477.511% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -221232.997% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -440.273% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1934.679% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5228.796% |
| Soligenix, Inc. | -4.95 Million USD | -3267.378% |
| Century Therapeutics, Inc. | 847 Thousand USD | 19785.832% |
| Kura Oncology, Inc. | -20.11 Million USD | -728.805% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -307.416% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1885.461% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9252.959% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5115.483% |
| Autolus Therapeutics plc | -186.59 Million USD | 10.643% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -238.186% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 39.542% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 586.573% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 201.442% |
| GRI Bio, Inc. | -1.79 Million USD | -9194.259% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1756.152% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -401.365% |
| IGM Biosciences, Inc. | -72.6 Million USD | -129.649% |
| INmune Bio, Inc. | -25.41 Million USD | -556.169% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 210.459% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -229.14% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -926.126% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5679.663% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 538.614% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -304.854% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 622.939% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 144.117% |
| Verastem, Inc. | -37.27 Million USD | -347.285% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1737.749% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -221.505% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1001.678% |
| Histogen Inc. | -7.48 Million USD | -2127.047% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -671.696% |
| Surrozen, Inc. | -32.66 Million USD | -410.467% |
| Organovo Holdings, Inc. | -1.5 Million USD | -10964.3% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3866.682% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 979.415% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6473.815% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4112.007% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1889.453% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -283.82% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1043.861% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 47.366% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -22992.125% |
| Apollomics, Inc. | -27.39 Million USD | -508.648% |
| Amarin Corporation plc | -191.04 Million USD | 12.72% |
| Mesoblast Limited | 55.96 Million USD | 397.945% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1043.301% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -559.256% |
| Synaptogenix, Inc. | -28.66 Million USD | -481.753% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -17713.996% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 442.155% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19241.275% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2194.759% |
| Exelixis, Inc. | -73.05 Million USD | -128.253% |
| Better Therapeutics, Inc. | -860 Thousand USD | -19288.256% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -594.37% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 30.92% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 22752.724% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2141.678% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 13396.571% |
| Gritstone bio, Inc. | 39.49 Million USD | 522.231% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -98.26% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6234.731% |
| Avid Bioservices, Inc. | 169.72 Million USD | 198.239% |
| Insmed Incorporated | 721.62 Million USD | 123.106% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1723.976% |
| MediWound Ltd. | -5.32 Million USD | -3033.014% |
| OmniAb, Inc. | 9.2 Million USD | 1911.79% |
| Alector, Inc. | -35.63 Million USD | -367.882% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 293.948% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3283.502% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1359.453% |
| Zai Lab Limited | -775 Million USD | 78.485% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 148.961% |
| Aura Biosciences, Inc. | -21.52 Million USD | -674.63% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -102.157% |
| Immunic, Inc. | -45.34 Million USD | -267.753% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 13.703% |
| Veracyte, Inc. | -203.82 Million USD | 18.195% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 126.123% |
| FibroGen, Inc. | 56.76 Million USD | 393.725% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1972.42% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5797.919% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -7953.67% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.632% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4890.691% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -0.467% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1033.484% |
| Galecto, Inc. | -21.21 Million USD | -685.912% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -601.026% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 110.624% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -581.346% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1349.022% |
| XBiotech Inc. | -200.02 Million USD | 16.64% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -98.26% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3782.398% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -372.844% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -115.933% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3029.872% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 2.157% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -80.504% |
| Vaxxinity, Inc. | 10.13 Million USD | 1745.667% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 122.647% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1448.532% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -152.803% |
| NexImmune, Inc. | -3.13 Million USD | -5220.932% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4729.273% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1003.395% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -515.273% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1757.598% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -133746.277% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -310.971% |
| Ainos, Inc. | 4.07 Million USD | 4188.817% |
| Pluri Inc. | 22.82 Million USD | 830.382% |
| Prothena Corporation plc | -608.34 Million USD | 72.591% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -40.405% |
| Celularity Inc. | 65.19 Million USD | 355.774% |
| Rallybio Corporation | -24.1 Million USD | -591.806% |
| Cue Biopharma, Inc. | -33.81 Million USD | -393.034% |
| MeiraGTx Holdings plc | -40.3 Million USD | -313.724% |
| Omeros Corporation | 331.17 Million USD | 150.348% |
| Humacyte, Inc. | -22.48 Million USD | -641.524% |
| Immunocore Holdings plc | -358.59 Million USD | 53.502% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -578.49% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -439.591% |
| Blueprint Medicines Corporation | 702.83 Million USD | 123.724% |
| CalciMedica, Inc. | -5.53 Million USD | -2915.172% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 11.413% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1532.455% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -316.462% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -401.425% |
| Pulmatrix, Inc. | -10.41 Million USD | -1500.643% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2689.677% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -337.153% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -49.673% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -178.158% |
| Cytokinetics, Incorporated | 642.37 Million USD | 125.957% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2763.455% |
| Nutriband Inc. | -251.65 Thousand USD | -66156.452% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -388.698% |
| Vor Biopharma Inc. | 4.3 Million USD | 3977.651% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.238% |
| Evogene Ltd. | -19.63 Million USD | -749.236% |
| ProKidney Corp. | -56.23 Million USD | -196.499% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -242.577% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1705.084% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.225% |
| CorMedix Inc. | -43.05 Million USD | -287.292% |
| BioLineRx Ltd. | 7.33 Million USD | 2372.887% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -507.096% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 461.321% |
| Atai Life Sciences N.V. | -28.55 Million USD | -483.861% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7575.312% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -630.799% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1040.169% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -122.1% |
| MediciNova, Inc. | -50.78 Million USD | -228.333% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -111.584% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -741126.939% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2484.064% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 16.556% |
| Biomea Fusion, Inc. | -166.57 Million USD | -0.101% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 6.837% |
| Mereo BioPharma Group plc | -51.46 Million USD | -223.96% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -75.803% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 43.24% |
| Absci Corporation | -72.59 Million USD | -129.674% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3751.752% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 28.877% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -76.985% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -74.238% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -326.737% |
| Allakos Inc. | -24.97 Million USD | -567.624% |
| Imunon, Inc. | -4.21 Million USD | -3856.926% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1031.047% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -23.145% |
| BioAtla, Inc. | -109.01 Million USD | -52.956% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 22752.724% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -17657.082% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1493.44% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -686.393% |
| XOMA Corporation | -29 Million USD | -474.962% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -906.878% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1749.368% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2138.408% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -33.781% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 19.9% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -103.89% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -79.747% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -19306.67% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4236.515% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10374.202% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.075% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -13933.675% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3897.29% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 246.931% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 231804.233% |
| Orgenesis Inc. | 21.78 Million USD | 865.42% |
| Entera Bio Ltd. | -10.62 Million USD | -1468.718% |
| GH Research PLC | -78.07 Million USD | -113.557% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -648.111% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -525.451% |
| Xencor, Inc. | 29.64 Million USD | 662.471% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8364.716% |
| Replimune Group, Inc. | 1.41 Million USD | 11908.711% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -67982.3% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -31.896% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -13933.675% |
| Portage Biotech Inc. | -4.98 Million USD | -3247.501% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -741126.939% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -152.169% |
| OncoCyte Corporation | -6.56 Million USD | -2440.591% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 18679.963% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3560.054% |
| Purple Biotech Ltd. | -14.13 Million USD | -1079.368% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -601.882% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2447.578% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -898.906% |
| HilleVax, Inc. | -165.48 Million USD | -0.758% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6469.701% |
| Tharimmune, Inc. | -10.93 Million USD | -1424.77% |
| Genprex, Inc. | -6.73 Million USD | -2374.743% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 54.79% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -88.491% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -11801.428% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4926.883% |
| OKYO Pharma Limited | -826.84 Thousand USD | -20065.617% |
| Savara Inc. | 153 Thousand USD | 109079.739% |
| Curis, Inc. | -23.88 Million USD | -598.032% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3132.685% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -21386.652% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2585.873% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14170.802% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.6% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1451.372% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 72.585% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 10.155% |
| Erasca, Inc. | -37.21 Million USD | -348.03% |
| bluebird bio, Inc. | 108.57 Million USD | 253.576% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -12846.65% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 144.024% |
| DBV Technologies S.A. | -126.98 Million USD | -31.305% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -12846.65% |
| Moderna, Inc. | -2.9 Billion USD | 94.264% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1510.694% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1434.22% |
| Molecular Templates, Inc. | 707 Thousand USD | 23684.017% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -431.507% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 148.106% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -103.187% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -81.772% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -416.668% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -385.045% |
| MacroGenics, Inc. | -66.98 Million USD | -148.92% |
| RenovoRx, Inc. | -1.17 Million USD | -14114.749% |
| Adicet Bio, Inc. | -138.78 Million USD | -20.14% |
| Prime Medicine, Inc. | -27.94 Million USD | -496.754% |
| Aditxt, Inc. | 18.12 Million USD | 1020.148% |
| Adagene Inc. | -87.62 Million USD | -90.282% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3902.926% |
| Quantum-Si incorporated | -118.55 Million USD | -40.64% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 563.1% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2130.864% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -243.728% |
| SciSparc Ltd. | -2.06 Million USD | -7974.528% |
| Vericel Corporation | 1.27 Million USD | 13157.087% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1290.453% |
| Minerva Neurosciences, Inc. | 41 Million USD | 506.638% |
| Generation Bio Co. | 31.44 Million USD | 630.205% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 4.918% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -439.207% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 243.009% |
| Invivyd, Inc. | -198.47 Million USD | 15.99% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -84.711% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6854.157% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -135.54% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2343.062% |
| 2seventy bio, Inc. | 181.71 Million USD | 191.759% |
| ADMA Biologics, Inc. | 90.06 Million USD | 285.13% |
| Clene Inc. | 3.34 Million USD | 5092.186% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1735.786% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -675.134% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2484.064% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 51.547% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -541.312% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 193.85% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3975.187% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3433.447% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3100.979% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -27.962% |
| Evaxion Biotech A/S | 5.28 Million USD | 3253.848% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -48.123% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -27.017% |
| Trevena, Inc. | 2.25 Million USD | 7484.367% |
| Surrozen, Inc. | -32.66 Million USD | -410.467% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -223.702% |
| Cingulate Inc. | 3.08 Million USD | 5508.892% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5577.188% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2420.008% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1694.585% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -110.203% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -26.844% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -57.984% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4129.124% |
| Kronos Bio, Inc. | -36.05 Million USD | -362.47% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1872.122% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11535.149% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -207.319% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1256.592% |
| ImmunityBio, Inc. | 618.22 Million USD | 126.971% |
| Korro Bio, Inc. | -132.94 Million USD | -25.421% |
| Kineta, Inc. | -4.54 Million USD | -3571.856% |
| BioVie Inc. | -17.73 Million USD | -840.31% |
| Codexis, Inc. | -43.27 Million USD | -285.337% |
| Celularity Inc. | 65.19 Million USD | 355.774% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5161.565% |
| Celcuity Inc. | 6.78 Million USD | 2558.005% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4855.179% |
| Cibus, Inc. | -8.07 Million USD | -1964.112% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3842.752% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3748.556% |
| IN8bio, Inc. | -16.38 Million USD | -917.384% |
| Kodiak Sciences Inc. | -103.87 Million USD | -60.519% |
| Annexon, Inc. | -193.75 Million USD | 13.943% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 463263.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -852.849% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4646.342% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 115.816% |
| Eyenovia, Inc. | 1.25 Million USD | 13346.9% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 719.732% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5041.505% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -401.516% |
| Arcellx, Inc. | -296.95 Million USD | 43.851% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -754.809% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -183.208% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -704.453% |
| Moolec Science SA | 117.61 Thousand USD | 141865.576% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -334.227% |
| Geron Corporation | 14.76 Million USD | 1229.591% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -339.736% |
| Royalty Pharma plc | 5.65 Billion USD | 102.947% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -17.903% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2285.59% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3009.144% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -18.481% |
| Humacyte, Inc. | -22.48 Million USD | -641.524% |
| Structure Therapeutics Inc. | -124.33 Million USD | -34.1% |
| 89bio, Inc. | -289.05 Million USD | 42.315% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -560.562% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9251.598% |
| Genelux Corporation | -6.89 Million USD | -2316.858% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -436.846% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 299.451% |
| Notable Labs, Ltd. | -9.77 Million USD | -1605.595% |
| Liquidia Corporation | -80.17 Million USD | -107.966% |
| Mustang Bio, Inc. | -3.73 Million USD | -4363.035% |
| Immunovant, Inc. | -635.22 Million USD | 73.751% |
| Quantum-Si incorporated | -118.55 Million USD | -40.64% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -849.322% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3924.596% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2177.227% |
| Acasti Pharma Inc. | -23 Million USD | -624.795% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4851.816% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -926.126% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -21.053% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5250.437% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -649.996% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -797.943% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 1.5% |
| PepGen Inc. | -60.67 Million USD | -174.829% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -625.709% |
| United Therapeutics Corporation | -507.7 Million USD | 67.158% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -771.792% |
| Solid Biosciences Inc. | -47.75 Million USD | -249.192% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19241.275% |
| Immuneering Corporation | -54.94 Million USD | -203.477% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3866.682% |
| Silo Pharma, Inc. | -3.52 Million USD | -4631.113% |
| Belite Bio, Inc | -87.27 Million USD | -91.059% |
| XOMA Corporation | -29 Million USD | -474.962% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -135.85% |
| Bionomics Limited | 227 Million USD | 173.45% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -43.392% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6482.669% |
| uniQure N.V. | -102.95 Million USD | -61.96% |
| Cassava Sciences, Inc. | -121.13 Million USD | -37.646% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3902.926% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 507.167% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1294.022% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5288.76% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 157400.943% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5041.505% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1972.42% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2148.368% |
| Altimmune, Inc. | -134.48 Million USD | -23.982% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 184.184% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6482.669% |
| Compugen Ltd. | -12.9 Million USD | -1192.15% |
| Peak Bio, Inc. | 10.34 Million USD | 1712.538% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -58818.375% |
| Benitec Biopharma Inc. | -50.58 Million USD | -229.641% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -59.807% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 948.76% |
| Zura Bio Limited | -99.8 Million USD | -67.063% |
| PolyPid Ltd. | 6.17 Million USD | 2802.415% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 324.958% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 948.76% |
| Instil Bio, Inc. | 75.35 Million USD | 321.263% |
| argenx SE | -2.02 Billion USD | 91.782% |
| Immunome, Inc. | -97.02 Million USD | -71.845% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -641.227% |
| Verona Pharma plc | -220.44 Million USD | 24.362% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -132.412% |
| Shattuck Labs, Inc. | -121.42 Million USD | -37.32% |
| CervoMed Inc. | -7.79 Million USD | -2039.642% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 10.113% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3712.92% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -26.567% |
| Moolec Science SA | 117.61 Thousand USD | 141865.576% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7187.617% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1148.78% |
| AnaptysBio, Inc. | -18.15 Million USD | -818.622% |
| Design Therapeutics, Inc. | -18.15 Million USD | -818.672% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -136.909% |
| NeurAxis, Inc. | 145.7 Thousand USD | 114539.945% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1584.5% |
| Lumos Pharma, Inc. | -28.49 Million USD | -485.193% |
| Achilles Therapeutics plc | -126.92 Million USD | -31.369% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -132.412% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -25327.996% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -702.64% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11535.149% |
| Nutriband Inc. | -251.65 Thousand USD | -66156.452% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1165.956% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2141.116% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 149.012% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 802.503% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 62.738% |
| Palisade Bio, Inc. | -12.06 Million USD | -1282.235% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -18.835% |
| Beam Therapeutics Inc. | -262.72 Million USD | 36.534% |
| Neurogene Inc. | -131.95 Million USD | -26.361% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 864.297% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3316.783% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 55.795% |
| Sesen Bio, Inc. | -112.55 Million USD | -48.143% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -66.973% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7001.946% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -327.251% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -100.21% |
| Athira Pharma, Inc. | -88.99 Million USD | -87.349% |
| Vaccinex, Inc. | -1.28 Million USD | -12845.575% |
| HCW Biologics Inc. | 2.85 Million USD | 5936.819% |
| XOMA Corporation | -29 Million USD | -474.962% |
| Nektar Therapeutics | 210.24 Million USD | 179.309% |
| Arvinas, Inc. | -313.8 Million USD | 46.865% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10374.202% |
| Merus N.V. | -192.88 Million USD | 13.555% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 377.968% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2303.272% |
| Rezolute, Inc. | -68.16 Million USD | -144.6% |
| Clene Inc. | 3.34 Million USD | 5092.186% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1164.42% |
| BeyondSpring Inc. | -13.75 Million USD | -1112.206% |
| Synlogic, Inc. | -6.68 Million USD | -2394.226% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 14803.616% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1872.076% |
| Peak Bio, Inc. | 10.34 Million USD | 1712.538% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -102.304% |
| Krystal Biotech, Inc. | -350.23 Million USD | 52.392% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 234.332% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 1.336% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5181.324% |
| MannKind Corporation | 143.89 Million USD | 215.872% |
| Ikena Oncology, Inc. | -109.15 Million USD | -52.753% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2102.338% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -403.743% |
| Gossamer Bio, Inc. | 180.35 Million USD | 192.45% |
| CohBar, Inc. | -5.93 Million USD | -2711.441% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -460.505% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3751.752% |
| Legend Biotech Corporation | -949.39 Million USD | 82.437% |
| Mural Oncology plc | -255.84 Million USD | 34.828% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 617.582% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3439.624% |
| Disc Medicine, Inc. | -358.28 Million USD | 53.461% |
| Champions Oncology, Inc. | 4.81 Million USD | 3565.067% |
| REGENXBIO Inc. | 54.76 Million USD | 404.446% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -61906.195% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -10.406% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1750.187% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -106.659% |
| Vaxart, Inc. | -8.24 Million USD | -1923.286% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -232.282% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -31.12% |
| Cellectis S.A. | -43.85 Million USD | -280.205% |
| Longeveron Inc. | -2.9 Million USD | -5633.803% |
| Repare Therapeutics Inc. | -107.85 Million USD | -54.591% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 117.218% |
| Inozyme Pharma, Inc. | 12 Million USD | 1489.029% |
| Revolution Medicines, Inc. | -608.2 Million USD | 72.585% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -13456.016% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 37.107% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -11.106% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -965.629% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -22432.297% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.257% |
| Denali Therapeutics Inc. | -74.86 Million USD | -122.72% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1290.453% |
| Veru Inc. | 4.77 Million USD | 3588.286% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1382.652% |
| Cingulate Inc. | 3.08 Million USD | 5508.892% |
| Passage Bio, Inc. | 4.58 Million USD | 3736.619% |
| Context Therapeutics Inc. | -14.44 Million USD | -1053.917% |
| Exicure, Inc. | 5.84 Million USD | 2950.727% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 27.623% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -321.377% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1162.641% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -183.468% |
| Nuvalent, Inc. | -335.38 Million USD | 50.285% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 9713.969% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -123.865% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1775.579% |
| OmniAb, Inc. | 9.2 Million USD | 1911.79% |
| Anew Medical, Inc. | 1.43 Million USD | 11740.005% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1117.834% |
| Lipocine Inc. | -4.75 Million USD | -3406.904% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -51.818% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1194.734% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -229.14% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 769.85% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2380.866% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -153.299% |
| Ocugen, Inc. | -32.52 Million USD | -412.712% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -94.845% |
| Q32 Bio Inc. | -37.94 Million USD | -339.388% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -26450.796% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1132.456% |
| Equillium, Inc. | -22.39 Million USD | -644.636% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -552.139% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -411.05% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -67156.519% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 224.393% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5313.852% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 50866.804% |
| Dominari Holdings Inc. | 195 Thousand USD | 85607.179% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3065.784% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1769.9% |
| Bio-Techne Corporation | 267.74 Million USD | 162.275% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -928.682% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -41.192% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1884.279% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1217.991% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 31.976% |
| Nkarta, Inc. | 57.29 Million USD | 390.998% |
| BioCardia, Inc. | 212 Thousand USD | 78750.472% |
| Iterum Therapeutics plc | 13.43 Million USD | 1340.802% |